710.52

0.28% -1.87

Idexx Laboratories Inc (IDXX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt IDXX? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$712.39

Offen:

$707.33

24-Stunden-Volumen:

81,341

Relative Volume:

0.15

Marktkapitalisierung:

$56.73B

Einnahmen:

$4.17B

Nettoeinkommen (Verlust:

$1.03B

KGV:

56.32

EPS:

12.6148

Netto-Cashflow:

$940.22M

1W Leistung:

+6.03%

1M Leistung:

+1.62%

6M Leistung:

+31.40%

1J Leistung:

+64.31%

1-Tages-Spanne:

$707.33

$715.35

1-Wochen-Bereich:

$667.65

$724.99

52-Wochen-Spanne:

$356.14

$769.98

Idexx Laboratories Inc Stock (IDXX) Company Profile

Firmenname

Idexx Laboratories Inc

Sektor

Healthcare (1117)

Branche

Diagnostics & Research (53)

Telefon

(207) 556-0300

Adresse

ONE IDEXX DRIVE, WESTBROOK, ME

Mitarbeiter

11,000

Twitter

@idexx

Nächster Verdiensttermin

2025-02-03

Neueste SEC-Einreichungen

IDXX's Discussions on Twitter

Vergleichen Sie IDXX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
IDXX Idexx Laboratories Inc	710.40	56.89B	4.17B	1.03B	940.22M	12.61
TMO Thermo Fisher Scientific Inc	611.37	227.87B	43.74B	6.58B	6.11B	17.31
DHR Danaher Corp	235.82	165.99B	24.27B	3.50B	5.02B	4.8589
A Agilent Technologies Inc	148.01	41.32B	6.95B	1.30B	1.15B	4.5696
IQV Iqvia Holdings Inc	246.63	41.42B	15.90B	1.28B	2.21B	7.2842

Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-09	Eingeleitet	Barclays	Overweight
2025-10-31	Hochstufung	Stifel	Hold → Buy
2025-10-01	Eingeleitet	UBS	Neutral
2025-08-05	Bestätigt	BTIG Research	Buy
2025-07-01	Eingeleitet	Jefferies	Buy
2024-12-02	Eingeleitet	Leerink Partners	Outperform
2024-07-25	Eingeleitet	BTIG Research	Buy
2024-01-30	Herabstufung	Piper Sandler	Overweight → Neutral
2023-12-07	Eingeleitet	Exane BNP Paribas	Outperform
2023-12-04	Hochstufung	Cleveland Research	Neutral → Buy
2023-08-02	Herabstufung	Atlantic Equities	Overweight → Neutral
2022-07-25	Herabstufung	Stifel	Buy → Hold
2022-07-21	Hochstufung	Goldman	Neutral → Buy
2022-07-12	Eingeleitet	Piper Sandler	Overweight
2022-05-05	Herabstufung	BofA Securities	Buy → Neutral
2022-02-08	Eingeleitet	Atlantic Equities	Overweight
2021-11-18	Eingeleitet	Morgan Stanley	Overweight
2021-08-05	Fortgesetzt	Credit Suisse	Outperform
2021-07-12	Herabstufung	Guggenheim	Buy → Neutral
2021-02-17	Eingeleitet	Barclays	Overweight
2019-09-09	Eingeleitet	Goldman	Neutral
2019-05-23	Eingeleitet	Guggenheim	Buy
2018-11-02	Bestätigt	BofA/Merrill	Buy
2018-05-07	Bestätigt	Stifel	Buy
2018-01-16	Eingeleitet	Piper Jaffray	Overweight
2017-08-23	Hochstufung	BofA/Merrill	Neutral → Buy
2017-07-28	Hochstufung	CL King	Neutral → Buy
2017-02-03	Herabstufung	Feltl & Co.	Hold → Sell
2016-09-29	Fortgesetzt	BofA/Merrill	Neutral
2016-08-16	Bestätigt	Stifel	Buy
2016-08-03	Hochstufung	Northcoast	Sell → Neutral
2016-07-20	Bestätigt	Canaccord Genuity	Buy
2016-04-19	Bestätigt	Canaccord Genuity	Buy
2016-04-01	Eingeleitet	CL King	Neutral
2016-03-21	Bestätigt	Stifel	Buy
2016-02-04	Eingeleitet	Credit Suisse	Outperform
2015-10-29	Bestätigt	Stifel	Buy
2015-08-28	Herabstufung	Raymond James	Outperform → Mkt Perform
2015-08-13	Bestätigt	Stifel	Buy
2015-07-23	Bestätigt	Canaccord Genuity	Buy

Alle ansehen

Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten

Jan 08, 2026

Is IDEXX Laboratories Inc. (IX1) stock at risk of policy regulationMarket Performance Summary & Real-Time Chart Pattern Alerts - ulpravda.ru

Jan 08, 2026

Fundamentals Check: How IDEXX Laboratories Inc. stock trades before earningsAnalyst Downgrade & Real-Time Sentiment Analysis - ulpravda.ru

Jan 08, 2026

Is IDEXX Laboratories Inc. (IX1) stock undervalued historicallyJuly 2025 Rallies & Expert Approved Trade Ideas - ulpravda.ru

Jan 08, 2026

Will IDEXX Laboratories Inc. stock deliver consistent dividends2025 Market Trends & Weekly High Conviction Ideas - ulpravda.ru

Jan 08, 2026

Is IDEXX Laboratories Inc. stock attractive after correction2025 Earnings Surprises & AI Powered Market Entry Strategies - ulpravda.ru

Jan 08, 2026

Can IDEXX Laboratories Inc. (IX1) stock deliver double digit returnsQuarterly Risk Review & Capital Efficient Trading Techniques - ulpravda.ru

Jan 08, 2026

Veterinary Infectious Disease Diagnostics Market Forecast, 2025-2035, Featuring IDEXX Labs, Zoetis, Thermo Fisher Scientific, Virbac, bioMerieux and More - Yahoo Finance

Jan 08, 2026

Palo Alto, Capital One Financial, IDEXX Laboratories And Others: CNBC's 'Closing Trades' - Bitget

Jan 08, 2026

Palo Alto, Capital One Financial, IDEXX Laboratories And More: CNBC's 'Final Trades' - Benzinga

Jan 08, 2026

Jan 07, 2026

Is the current sentiment towards IDEXX Laboratories Inc positive or negative in the market? - Bitget

Jan 07, 2026

What catalysts could drive IDEXX Laboratories Inc. stock higher2026 world cup usa national team third place match young talents set piece tactics winner prediction tactical review - ulpravda.ru

Jan 06, 2026

IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch

Jan 06, 2026

What to expect from IDEXX Laboratories’ next quarterly earnings report - MSN

Jan 06, 2026

2026 world cup key players explained: Can IDEXX Laboratories Inc. stock deliver surprise earnings beat2026 world cup usa national team round of 16 playmakers high defensive line odds analysis preview - ulpravda.ru

Jan 06, 2026

Jan 05, 2026

IDEXX Laboratories' SWOT analysis: stock outlook amid vet visit trends - MSN

Jan 05, 2026

What to Expect From IDEXX Laboratories’ Next Quarterly Earnings Report? - Barchart.com

Jan 05, 2026

Railway Pension Investments Ltd Has $189.45 Million Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat

Jan 05, 2026

Jan 04, 2026